The whole archive,
searchable

The questions diligence teams ask customers, former colleagues and co-investors, and how answers are weighted in the final memo.

Position sizing, pacing across vintages, reserve strategy and the number of investments needed for a durable return profile.

Which chapters co-invested this quarter, the structures used and the practical friction founders should plan for.

Regulatory pathways, reimbursement realities and the clinical evidence thresholds that shape health investments in the region.

How to decide when to double down, when to hold and how to price information rights against dilution in later rounds.

Realisations, mark-ups and write-offs across the network portfolio, with the cohort analysis behind each figure.